Related Experiment Video
Updated: Jun 4, 2025

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
THE FAM53C/DYRK1A axis regulates the G1/S transition of the cell cycle
Abstract:
A growing number of therapies are being developed to target the cell cycle machinery for the treatment of cancer and other human diseases. Consequently, a greater understanding of the factors regulating cell cycle progression becomes essential to help enhance the response to these new therapies. Here, using data from the Cancer Dependency Map, we identified the poorly-studied factor FAM53C as a new regulator of cell cycle progression. We found that FAM53C is critical for this cell cycle transition and that it acts upstream of the CyclinD-CDK4/6-RB axis in the regulation of the G1/S transition. By mass spectrometry, biochemical, and cellular assays, we identified and validated DYRK1A as a cell cycle kinase that is inhibited by and directly interacts with FAM53C. DYRK1A kinase inhibition rescues the G1 arrest induced by FAM53C knock-down. Consistent with the role for FAM53C identified in cells in culture, FAM53C knockout human cortical organoids display increased cell cycle arrest and growth defects. In addition, Fam53C knockout mice show defects in body growth and behavioral phenotypes. Because DYRK1A dysregulation contributes to developmental disorders such as Down syndrome as well as tumorigenesis, future strategies aiming at regulating FAM53C activity may benefit a broad range of patients.
Insights
Researchers discovered FAM53C regulates cell cycle progression, acting upstream of the CyclinD-CDK4/6-RB pathway. FAM53C interacts with and inhibits DYRK1A kinase, impacting cell cycle control and organismal growth.
Area of Science:
- Cell Biology
- Molecular Oncology
- Developmental Biology
Background:
- Targeting cell cycle machinery is crucial for cancer therapy.
- Understanding cell cycle regulators enhances therapeutic responses.
- FAM53C was a poorly-studied factor with unknown function.
Purpose of the Study:
- Identify novel regulators of cell cycle progression.
- Investigate the role of FAM53C in cell cycle control.
- Elucidate the molecular mechanism of FAM53C action.
Main Methods:
- Utilized Cancer Dependency Map data.
- Performed mass spectrometry, biochemical, and cellular assays.
- Generated FAM53C knockout organoid and mouse models.
Main Results:
- Identified FAM53C as a novel cell cycle regulator.
- FAM53C acts upstream of the CyclinD-CDK4/6-RB axis.
- Discovered DYRK1A kinase is inhibited by FAM53C, rescuing G1 arrest.
- FAM53C knockout models exhibit growth defects and behavioral phenotypes.
Conclusions:
- FAM53C is a critical regulator of the G1/S cell cycle transition.
- FAM53C directly interacts with and inhibits DYRK1A kinase.
- Dysregulation of FAM53C impacts organismal development and growth.
- Targeting FAM53C may offer therapeutic potential for cancer and developmental disorders.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cells Coordinate Growth and Proliferation
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Positive Regulator Molecules